ADVANTIS CORPORATION (OTC PINK: ADVT) announced that it is in the process of securing a pair of industrial packaging locations in Los Angeles and Orange County, that are also licensed for distribution. Advantis CEO, Darren Cherry, says, “The source of our sales volume dictates where we need to be. These new locations will both be able to support the larger, more efficient canning machine in each of them.”
According to Cherry, Advantis orders continue to rise month over month, and production continues to increase to meet the demand. “Current clients order more, word spreads and we acquire brand new clients and partners that further expand our footprint,” Cherry explained. “It seems exponential. With these two locations, we’ll be able to produce nearly half a ton more than what we are currently producing every week.” Advantis currently has smaller canning machines at full production capacity in Oregon and Las Vegas ramping up, and one larger machine that produces cans 9 times faster is centrally located in the Inland Empire of California. “Inland Empire is humming along, but the volume requested by some new clients necessitates that we set up shop closer to where their final distribution takes place. That’s the beauty of our mobile and flexible business model; it allows us to be nimble when the marketplace has new demands. The pace of growth we are experiencing allows us to have the cash flow and relationships to expand when necessary, and that’s exactly what we’re doing,” Cherry concluded. “We expect both machines to be at full capacity around the clock, as soon as we move in.”
Cherry says the relationship with its partner in Oregon has been steadily growing. “We were so proud when we announced our partnership with Gesundheit Foods in Oregon. We are even more proud to announce their name and that they will be partnering with us to manufacture and distribute our most recent product development: sublingual THC and CBD strips – the Amster-Strip.” Gesundheit Foods, Inc. is a major national health food packer, copacker, and bottler, that takes pride in what they do and who they work with. “We are licensing the formula and technology to Gesundheit for use in Oregon. We have further developed a marketing plan to manufacture and distribute the sublingual strips throughout the cannabis and health food marketplaces.” Cherry says the relationship with Gesundheit has been solid and growing, as evidenced by this new agreement. “The next step is to help them get to full Amster-Can capacity on one of our larger machines. This is a fantastic partnership, that I couldn’t be any happier with.”
In addition to the news about these significant production and revenue increases, Cherry announced that he has been taking the appropriate steps to make Advantis an SEC fully reporting company. “While we continue to expand, upgrade our digital presence, and develop new product lines, I recognize the need for our company to have greater transparency, exposure and access to the global marketplace. We have been meeting with our attorneys and responsibly laying the groundwork to go fully reporting and potentially upgrade from the OTC market. My predecessors put some pieces in place to do this, but we are now actively moving forward.” With today’s announcement about increased orders and production capacity paired with upcoming product launches, Cherry says the future of the company will eventually rely on greater exposure. “We are on the leading edge of the cannabis marketplace, but not getting the eyes on the company that we need to help us grow even faster. When we are a fully reporting company, we will be held to a higher standard that investors can trust and rely upon. It can help fuel our capacity to grow faster when the marketplace demands because more investors will be able to see the amazing growth that we have been experiencing and will continue to experience at this leading edge of the ‘green rush.’ This potentially means that the increased liquidity will allow us to finally get ahead of demand instead of always catching up to it.” Cherry concluded his comments by stating investors should expect the announcement of another quarterly revenue record for Q1 later this month.
Advantis is quickly scaling its business to handle the increased demand of its flagship product, Amster-Can. Advantis wishes to thank Investors Hangout for mentioning the company in their podcast.
Links to Advantis websites can be found at advantiscorp.com, rosin6.com, elixicure.com, and amstercan.com
<b>About Advantis Corporation</b>
Advantis Corporation (ADVT) focuses on the development of innovative products that supply the medical, research, and pharmaceutical industries. The company additionally establishes partnerships with businesses that develop and sell proprietary pain management, and consumer products and services.
Forward Looking Statements: This news release contains forward-looking statements made by ADVANTIS CORPORATION. All such statements included in this press release, other than statements of historical fact, are forward-looking statements. Although management believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. Actual results may differ materially from those indicated by these statements. The following risk factors, among others, could cause actual results to differ materially from those described in any forward- looking statements. These risks and uncertainties include, but are not limited to, economic conditions, changes in the law or regulations, demand for products of the Company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward looking statements. Forward- looking statements are typically identified by the words: believe, expect, anticipate, intend, estimate, and similar expressions or which by their nature refer to future events. The Company is not entitled to rely on the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 because it is not registered under either Act.
For further information, contact:Media Relations Contact Name: Woo Kim, DirectorOrganization: Advantis CorporationPhone: 949-354-3585Address: 1048 Irvine Ave. #900 Newport Beach, CA 92660E-mail: firstname.lastname@example.org
<img src=”http://www.globenewswire.com/newsroom/ti?ndecode=MTUwIzczMDE1OTk=” alt=”” width=”1″ height=”1″/>